1. An extended-release capsule dosage form of metoprolol succinate comprising coated discrete units having a d90 value between about 0.2 mm and 1.5 mm, wherein the coated discrete units, after dispersing in an aqueous media for at least 10 minutes, have a desired flowability when passed through a feeding tube...
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of U.S. application Ser. No. 15/012,775 filed Feb. 1, 2016, which is a continuation of PCT Application No. PCT/IB2015/055195 filed Jul. 9, 2015, which claims the benefit of U.S. Provisional Application No. 62/022,316 filed Jul. 9, 2014.